...
首页> 外文期刊>Journal of pharmaceutical sciences. >Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.
【24h】

Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.

机译:氟安汀的脂蛋白分布差异受脂蛋白非极性脂质和蛋白质浓度以及脂质转移蛋白I活性的调节:在正常血脂和血脂异常人血浆中的体外研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of these studies was to determine the distribution of a lipophilic antimalarial agent, halofantrine hydrochloride (Hf), in fasted plasma from hypo-, normo-, and hyperlipidemic patients that displayed differences in lipoprotein concentration and lipid transfer protein I (LTP I) activity. To assess the influence of modified lipoprotein concentrations and LTP I activity on the plasma distribution of Hf, Hf at a concentration of 1000 ng/mL was incubated in either hypo-, normo-, or hyperlipidemic human plasma for 1 h at 37 degreesC. Following incubation, the plasma samples were separated into their lipoprotein and lipoprotein-deficient plasma (LPDP) fractions by density gradient ultracentrifugation and assayed for Hf by high-pressure liquid chromatography. The activity of LTP I in the dyslipidemic plasma samples was determined in terms of its ability to transfer cholesteryl ester from low-density lipoproteins (LDL) to high-density lipoproteins (HDL). Total plasma and lipoprotein cholesterol (esterified and unesterified), triglyceride, and protein levels in the dyslipidemic plasma samples were determined by enzymatic assays. When Hf was incubated in normolipidemic plasma for 1 h at 37 degreesC, the majority of drug was found in the LPDP fraction. When Hf was incubated in human plasma of varying total lipid, lipoprotein lipid, and protein concentrations and LTP I activity, the following relationships were observed. As the triglyceride-rich lipoprotein (TRL) lipid and protein concentration increased from hypolipidemia through to hyperlipidemia, the proportion of Hf associated with TRL increased (r > 0.90). As the HDL lipid and protein concentration increased, the proportion of Hf associated with HDL decreased (r > 0.70). As the total and lipoprotein lipid levels increased, the LTP I activity of the plasma also proportionally increased (r > 0.85). Furthermore, with the increase in LTP I activity, the proportion of Hf associated with the TRL fraction increased (r > 0.70) and the proportion of Hf associated with the HDL fraction decreased (r > 0.80). In addition, a positive correlation between the proportion of apolar lipid and Hf recovered within each lipoprotein fraction was observed within hypo- (r > 0.80), normo- (r = 0.70), and hyperlipidemic (r > 0.90) plasmas. These findings suggest that changes in the HDL and TRL lipid and protein concentrations, LTP I activity, and the proportion of apolar lipid within each lipoprotein fraction may influence the plasma lipoprotein distribution of Hf in dyslipidemia.
机译:这些研究的目的是确定低脂,正常血脂和高脂血症患者在禁食血浆中脂溶性抗疟疾药物盐酸氟替林盐酸盐(Hf)的分布,这些患者在脂蛋白浓度和脂质转移蛋白I(LTP I)方面表现出差异活动。为了评估修饰的脂蛋白浓度和LTP I活性对Hf血浆分布的影响,将1000 ng / mL浓度的Hf在低血脂,正常血脂或高血脂的人血浆中于37°C孵育1小时。孵育后,通过密度梯度超速离心将血浆样品分离为脂蛋白和脂蛋白缺乏血浆(LPDP)馏分,并通过高压液相色谱法测定Hf。根据其将胆固醇酯从低密度脂蛋白(LDL)转移到高密度脂蛋白(HDL)的能力,确定了血脂异常血浆样品中LTP I的活性。通过酶法测定血脂异常血浆样品中的总血浆和脂蛋白胆固醇(酯化和未酯化),甘油三酸酯和蛋白质水平。当Hf在正常血脂血浆中于37摄氏度孵育1小时时,在LPDP馏分中发现了大部分药物。当Hf在总脂质,脂蛋白脂质,蛋白质浓度和LTP I活性各不相同的人血浆中孵育时,观察到以下关系。随着富含甘油三酸酯的脂蛋白(TRL)的脂质和蛋白质浓度从低脂血症到高脂血症增加,与TRL相关的Hf比例增加(r> 0.90)。随着HDL脂质和蛋白质浓度的增加,与HDL相关的Hf比例降低(r> 0.70)。随着总脂蛋白和脂蛋白脂水平的增加,血浆的LTP I活性也成比例增加(r> 0.85)。此外,随着LTP I活性的增加,与TRL分数相关的Hf比例增加(r> 0.70),而与HDL分数相关的Hf比例降低(r> 0.80)。此外,在低血浆(r> 0.80),正常血浆(r = 0.70)和高脂血症(r> 0.90)血浆中观察到每个脂蛋白组分中回收的非极性脂质与Hf的比例呈正相关。这些发现表明,HDL和TRL脂质和蛋白质浓度,LTP I活性以及每个脂蛋白组分中非极性脂质的比例的变化可能影响血脂异常中Hf的血浆脂蛋白分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号